Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg ‐negative, HBcAb‐positive rheumatoid arthritis patients: A long‐term, real‐world observation

ConclusionBaseline HBsAb positivity was a significant protective factor for rHBV in HBsAg ‐negative, HBcAb‐positive RA patients receiving rituximab therapy.

Source: International Journal of Rheumatic Diseases - May 21, 2019 Category: Rheumatology Authors: Yi ‐Ming Chen, Hsin‐Hua Chen, Wen‐Nan Huang, Yi‐Hsing Chen, Tsu‐Yi Hsieh, Sheng‐Shun Yang, Joung‐Liang Lan, Der‐Yuan Chen Tags: ORIGINAL ARTICLE Source Type: research